OTCMKTS:EDTXF Spectral Diagnostics (EDTXF) Stock Price, News & Analysis $0.61 +0.01 (+2.24%) As of 06/27/2025 12:14 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock About Spectral Diagnostics Stock (OTCMKTS:EDTXF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Spectral Diagnostics alerts:Sign Up Key Stats Today's Range$0.61▼$0.6150-Day Range$0.56▼$0.6552-Week Range$0.32▼$0.65Volume334 shsAverage Volume6,370 shsMarket Capitalization$174.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSpectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.Read More… Spectral Diagnostics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks9th Percentile Overall ScoreEDTXF MarketRank™: Spectral Diagnostics scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Spectral Diagnostics. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Spectral Diagnostics is -8.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Spectral Diagnostics is -8.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Spectral Diagnostics' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.03% of the float of Spectral Diagnostics has been sold short.Short Interest Ratio / Days to CoverSpectral Diagnostics has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Spectral Diagnostics has recently decreased by 14.24%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSpectral Diagnostics does not currently pay a dividend.Dividend GrowthSpectral Diagnostics does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.03% of the float of Spectral Diagnostics has been sold short.Short Interest Ratio / Days to CoverSpectral Diagnostics has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Spectral Diagnostics has recently decreased by 14.24%, indicating that investor sentiment is improving significantly. News and Social Media1.5 / 5News SentimentN/A News SentimentSpectral Diagnostics has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Spectral Diagnostics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.50% of the stock of Spectral Diagnostics is held by insiders.Read more about Spectral Diagnostics' insider trading history. Receive EDTXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Spectral Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address EDTXF Stock News HeadlinesSpectral Medical Inc. Announces Results of Annual Meeting of ShareholdersJune 6, 2025 | globenewswire.comSpectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor ConferenceMay 16, 2025 | globenewswire.comTrump Knows Exactly What He’s Doing…With Trump in office, new money is flowing in and out of the market like never before... And some folks using my strategy are making a fast fortune... no matter which way the market moves. This is the same one-ticker strategy I used to make more $95 million in verified profits for my clients during the 2008 financial crisis. But now... with Trump sending about $240 billon into the markets every week on specific, pre-determined dates... | Brownstone Research (Ad)Spectral Medical Announces First Quarter and Provides Corporate UpdateMay 9, 2025 | globenewswire.comSpectral Medical Announces Non-Dilutive Financing of Up to $10 Million with VantiveMay 7, 2025 | globenewswire.comSpectral Medical Inc.: Spectral Medical Completes Tigris Trial EnrollmentApril 16, 2025 | finanznachrichten.deSpectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate UpdateMarch 27, 2025 | globenewswire.comSpectral Medical Inc. (EDTXF)February 12, 2025 | finance.yahoo.comSee More Headlines EDTXF Stock Analysis - Frequently Asked Questions How have EDTXF shares performed this year? Spectral Diagnostics' stock was trading at $0.3474 at the beginning of the year. Since then, EDTXF stock has increased by 75.7% and is now trading at $0.6103. View the best growth stocks for 2025 here. How were Spectral Diagnostics' earnings last quarter? Spectral Diagnostics Inc. (OTCMKTS:EDTXF) announced its earnings results on Friday, May, 9th. The company reported ($0.03) EPS for the quarter. The company had revenue of $0.40 million for the quarter. How do I buy shares of Spectral Diagnostics? Shares of EDTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/09/2025Today6/28/2025Next Earnings (Estimated)8/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryN/A Current SymbolOTCMKTS:EDTXF Previous SymbolOTCMKTS:DIAGF CIKN/A Webwww.spectraldx.com Phone(416) 626-3233Fax416-626-7383Employees29Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.24 million Net Margins-1,078.10% Pretax Margin-1,077.59% Return on EquityN/A Return on Assets-336.97% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.08 Sales & Book Value Annual Sales$1.67 million Price / Sales104.34 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-8.72Miscellaneous Outstanding Shares285,520,000Free Float281,237,000Market Cap$174.25 million OptionableNot Optionable Beta0.23 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:EDTXF) was last updated on 6/28/2025 by MarketBeat.com Staff From Our PartnersGold Just Jumped Again. Here’s How to Get PaidGold prices just spiked again. As I write this, gold is trading near $3,400 an ounce. But here's the thi...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Shocking Link Between A.I. and Your MoneyThe AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump Knows Exactly What He’s Doing…With Trump in office, new money is flowing in and out of the market like never before... And some folks usi...Brownstone Research | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're currently collecting—or planning to collect—Social Security benefits, there's an urgent development ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectral Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.